Featured this week:
- Risk of Recurrence and Cancer Stem Cell Marker CD133 Expression Vary in Males Versus Females with Papillary Thyroid Cancer. Chang J, Alzayadneh EM, Rajan A, Tran A, Weigel RJ, Beck AC. Ann Surg Oncol. 2025 Apr 11. doi: 10.1245/s10434-025-17256-2. Online ahead of print. PMID: 40214912